The Effects of Timolol On Healing and Cosmesis of Mohs Scalp Wounds: An Open Label Trial

StatusNot Yet Recruiting
PhasePhase 2
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Jul 1, 2026 to Dec 1, 2026 Show 4 more changesShow less
    • Enrollment increased: 40 → 45 participants
    • Primary completion date: Jul 2028 to Jul 1, 2028
    • Study completion date: Mar 2029 to Mar 1, 2029
    • Eligibility criteria expanded, about 11 words
  2. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
The goal of this study clinical trial is to learn if topical timolol can accelerate healing and improve the cosmetic appearance of surgical wounds on the scalp following Mohs surgery. It will include Geisinger patients 18 year or older who undergo Mohs surgery of the scalp with planned wound healing by secondary intent. The main questions in aim to answer are: 1. Compare wound healing speed between patients treated with topical timolol and those receiving standard wound care only. 2. Compare cosmetic outcomes using topical timolol and standard wound care. 3. Evaluate the impact of topical timolol on the number of unplanned follow-up visits and calls related to delayed wound healing. Participants will be asked use either topical timolol or use standard wound care to treat their Mohs surgery scalp wound. They will follow-up around 4, 8 and 12 weeks.
Trial Details
NCT Number NCT07583862
Lead Sponsor Geisinger Clinic
Conditions
(from sponsor)		 Surgical Wounds, Mohs Surgery
Related terms Cicatrix, Surgical Wound
Enrollment 45 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov